Division of Gastroenterology & Hepatology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Biochem Biophys Res Commun. 2011 Nov 18;415(2):319-24. doi: 10.1016/j.bbrc.2011.10.052. Epub 2011 Oct 18.
Mammalian matrix metalloproteinases (MMPs) which degrade extracellular matrix facilitate colon cancer cell invasion into the bloodstream and extra-colonic tissues; in particular, MMP1 expression correlates strongly with advanced colon cancer stage, hematogenous metastasis and poor prognosis. Likewise, muscarinic receptor signaling plays an important role in colon cancer; muscarinic receptors are over-expressed in colon cancer compared to normal colon epithelial cells. Muscarinic receptor activation stimulates proliferation, migration and invasion of human colon cancer cells. In mouse intestinal neoplasia models genetic ablation of muscarinic receptors attenuates carcinogenesis. In the present work, we sought to link these observations by showing that MMP1 expression and activation plays a mechanistic role in muscarinic receptor agonist-induced colon cancer cell invasion. We show that acetylcholine, which robustly increases MMP1 expression, stimulates invasion of HT29 and H508 human colon cancer cells into human umbilical vein endothelial cell monolayers - this was abolished by pre-incubation with atropine, a non-selective muscarinic receptor inhibitor, and by pre-incubation with anti-MMP1 neutralizing antibody. Similar results were obtained using a Matrigel chamber assay and deoxycholyltaurine (DCT), an amidated dihydroxy bile acid associated with colon neoplasia in animal models and humans, and previously shown to interact functionally with muscarinic receptors. DCT treatment of human colon cancer cells resulted in time-dependent, 10-fold increased MMP1 expression, and DCT-induced cell invasion was also blocked by pre-treatment with anti-MMP1 antibody. This study contributes to understanding mechanisms underlying muscarinic receptor agonist-induced promotion of colon cancer and, more importantly, indicates that blocking MMP1 expression and activation has therapeutic promise to stop or retard colon cancer invasion and dissemination.
哺乳动物基质金属蛋白酶(MMPs)可降解细胞外基质,促进结肠癌细胞侵袭血流和结外组织;特别是,MMP1 的表达与晚期结肠癌、血行转移和预后不良密切相关。同样,毒蕈碱受体信号在结肠癌中也起着重要作用;与正常结肠上皮细胞相比,毒蕈碱受体在结肠癌中过度表达。毒蕈碱受体激活可刺激人结肠癌细胞的增殖、迁移和侵袭。在小鼠肠道肿瘤模型中,毒蕈碱受体的基因缺失可减弱致癌作用。在本研究中,我们试图将这些观察结果联系起来,表明 MMP1 的表达和激活在毒蕈碱受体激动剂诱导的结肠癌细胞侵袭中起着机制作用。我们发现,乙酰胆碱可强烈增加 MMP1 的表达,刺激 HT29 和 H508 人结肠癌细胞侵袭人脐静脉内皮细胞单层-这可被阿托品(一种非选择性毒蕈碱受体抑制剂)预孵育和抗 MMP1 中和抗体预孵育所阻断。使用 Matrigel 室测定和脱氧胆酰基牛磺酸钠(DCT)也获得了类似的结果,DCT 是一种与动物模型和人类结肠癌相关的酰胺化二羟胆酸,先前已显示与毒蕈碱受体具有功能相互作用。DCT 处理人结肠癌细胞导致 MMP1 表达呈时间依赖性增加 10 倍,抗 MMP1 抗体预处理也可阻断 DCT 诱导的细胞侵袭。本研究有助于了解毒蕈碱受体激动剂诱导促进结肠癌的机制,更重要的是表明阻断 MMP1 的表达和激活具有治疗潜力,可阻止或延缓结肠癌的侵袭和扩散。